Australia markets close in 4 hours 59 minutes

HTG Molecular Diagnostics, Inc. (65H.F)

Frankfurt - Frankfurt Delayed price. Currency in USD
Add to watchlist
0.0000-7.6860 (-100.00%)
At close: 09:36AM CEST
Currency in

Valuation measures4

Market cap (intra-day) 2.69k
Enterprise value -2.41M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.08
Price/book (mrq)0.58
Enterprise value/revenue -0.39
Enterprise value/EBITDA 0.13

Trading information

Stock price history

Beta (5Y monthly) 2.98
52-week change 30.00%
S&P500 52-week change 322.38%
52-week high 30.6405
52-week low 30.6405
50-day moving average 30.6405
200-day moving average 30.6405

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 52.21M
Implied shares outstanding 64.5M
Float 82.11M
% held by insiders 12.00%
% held by institutions 10.00%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:12
Last split date 321 Dec 2022

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)31 Mar 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-485.48%

Management effectiveness

Return on assets (ttm)-62.26%
Return on equity (ttm)-343.21%

Income statement

Revenue (ttm)6.21M
Revenue per share (ttm)4.87
Quarterly revenue growth (yoy)-12.80%
Gross profit (ttm)N/A
EBITDA -19.1M
Net income avi to common (ttm)-20.15M
Diluted EPS (ttm)-26.8000
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)6.56M
Total cash per share (mrq)2.96
Total debt (mrq)7.8M
Total debt/equity (mrq)1,643.20%
Current ratio (mrq)1.40
Book value per share (mrq)0.21

Cash flow statement

Operating cash flow (ttm)-16.83M
Levered free cash flow (ttm)-9.91M